Journal
CELL REPORTS
Volume 27, Issue 1, Pages 226-+Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2019.03.029
Keywords
-
Categories
Funding
- Outstanding Investigator Award from NIH/NCI [R35CA197725]
- NIH/NINDS [R01NS093903]
- NIH/NCI [1F32NS098737-01A1, R35CA197532]
Ask authors/readers for more resources
The mechanisms by which regulatory T cells (Tregs) migrate to and function within the hypoxic tumor microenvironment are unclear. Our studies indicate that specific ablation of hypoxia-inducible factor 1 alpha (HIF-1 alpha) in Tregs results in enhanced CD8(+) T cell suppression versus wild-type Tregs under hypoxia, due to increased pyruvate import into the mitochondria. Importantly, HIF-1 alpha-deficient Tregs are minimally affected by the inhibition of lipid oxidation, a fuel that is critical for Treg metabolism in tumors. Under hypoxia, HIF-1 alpha directs glucose away from mitochondria, leaving Tregs dependent on fatty acids for mitochondrial metabolism within the hypoxic tumor. Indeed, inhibition of lipid oxidation enhances the survival of mice with glioma. Interestingly, HIF-1 alpha-deficient-Treg mice exhibit significantly enhanced animal survival in a murine model of glioma, due to their stymied migratory capacity, explaining their reduced abundance in tumor-bearing mice. Thus HIF-1 alpha acts as a metabolic switch for Tregs between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available